Our research and related products in regenerative medicine is centered specifically around human stem cells. We utilize adipose derived mesenchymal stem cells as well as umbilical cord stem cells that are cultured using a totally animal origin free medium.
AOF is in the process of initiating several clinical trial programs in collaboration with medical universities and clinical institutions across Japan and abroad.
In addition we are proceeding with our Clinical Research that is aimed at providing effective advanced therapies to patients. We are working closely with some of the best clinical doctors in this field to enhance our Research and Development. This includes donor selection criteria, pre and post treatment protocol, evaluation system and software, and administration devices.
Our group company is operating a Cell Processing Facility that is approved by the Japanese Ministry of Health, Labor and Welfare and our contracted clinic has safely performed over 2000 stem cells procedures in compliance with domestic laws.
We are making a substantial investment in a dedicated building in central Tokyo that will be one of Japan’s first fully integrated Regenerative Medicine Complex. The new complex will include upgraded Cell Processing Facilities, a Research & Development center, a Regenerative Medicine Clinic and Medical Support Facilities.
2-16-9 Higashi, Shibuya-ku, Tokyo 150-0011 Japan
AOF North America
Representative office Scottsdale
SCOPE OF ACTIVITIES
Stem Cell Manufacturing & Banking/Storage
◆A Cell Processing Center (CPC) accredited by the Ministry of Health, Welfare and Labor of Japan
◆Products currently manufactured utilizing our totally Animal Origin Free medium: Adipose-Derived Mesenchymal Stem Cell and its derivative (Supernatant), Umbilical Cord derived Stem Cell and its derivative (Supernatant)
◆Stem cell banking facility within the CPC
Drug development and Clinical Trials
◆First class Research & Development Center
◆Pipeline of Clinical Trials targeting unmet and rare diseases
◆Strong Intellectual Property Portfolio
Clinical Research and Medical Services
◆Research with outside contracted Clinics and Medical institutions.
◆Creation of protocol and software for each targeted disease
◆Advanced data collection system through OBQI – Outcome- Based Quality Improvement.
◆Data Analysis and implementation of proven therapies.
Cosmetic Products and Devises
◆Proprietary 3300-micron micro-needle pad for advanced medical and cosmetic applications
◆Stem Cell extract derivative (supernatant) to be administered by licensed Doctors
◆Related software applications